We observed an increase in the expression of the Casp3 gene in the stroke (0.0062-fold) and telmisartan (0.0121-fold) groups, which was more significant in the latter group than the control group (0.0041-fold), while the EAOr fraction significantly decreased the expression of Casp3 (0.0034-fold), when compared to the stroke group (Figure 6). This evidence concerns the gene CASP3 and Stroke.